|Articles|May 2, 2015
Jasmine Martin Discusses Oral Adherence
Author(s)Jasmine Martin
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
Advertisement
Jasmine Martin, Director, West Region Medical Science Liaison Team, Takeda Oncology, discusses oral adherence.
“If patients aren’t taking their drugs, then how do we know that the outcomes will be [the same as] what the clinical trial [outcomes] were?” Martin asks.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
‘Full House’ Star Dave Coulier Talks Tongue Cancer Diagnosis
2
New Approach May Offer Stronger Treatment Effects in Metastatic Breast Cancer
3
Updated Treatment Options Improve Advanced HR+ Breast Cancer Outcomes
4
Stage 4 Pancreatic Cancer Survivor Shares Clinical Trial Path
5